共 50 条
- [31] Pan-HER inhibition in EGFR wild-type non-small-cell lung cancerLANCET ONCOLOGY, 2014, 15 (12): : 1289 - 1290Peters, SolangeSmit, Egbert
- [32] Examination of the importance of RUNX category in EGFR wild-type non-small cell lung cancerCANCER SCIENCE, 2021, 112 : 445 - 445Kobayakawa, AtsushiTakeda, KanakoMasuda, TatuyaYanagida, YoheiObi, NatsunoSakuramoto, NaoyaHada, AsukaHoriuchi, AyakaTakeda, MizuhoSasaki, AsamiMatsuo, HidemasaSugiyama, HiroshiAdachi, SouichiKamikubo, Yasuhiko
- [33] Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFRINTERNATIONAL JOURNAL OF CANCER, 2014, 135 (12) : 2962 - 2971Ren, ShengxiangSu, ChunxiaWang, ZhaoyeLi, JiayuFan, LihongLi, BingLi, XuefeiZhao, CaoWu, ChunyanHou, LikunHe, YayiGao, GuanghuiChen, XiaoxiaRen, JiaweiLi, AiwuXu, GuotongZhou, XiaoZhou, CaicunSchmid-Bindert, Gerald
- [34] Concurrent EGFR wild-type tongue squamous cell carcinoma and EGFR-mutant lung adenocarcinoma and response to osimertinibJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Wu, FangHu, ChunhongZhang, SujuanWang, ShuxingPan, YueHe, FengjiaoLu, CanFu, YuchengZeng, YueLiu, JunqiShi, ShenghaoPeng, YurongXiao, Chaoyue
- [35] Internalization systems of EGFR could affect the efficacy of gefitinib in NSCLCs with wild-type EGFREJC SUPPLEMENTS, 2010, 8 (07): : 99 - 99Jo, U.Sung, J. S.Jung, H. Y.Park, K. H.Jung, H. N.Whang, Y. M.Kim, Y. H.
- [36] ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case reportFRONTIERS IN ONCOLOGY, 2024, 14Chen, RuiJian, YanLiu, YuzhenXie, Junping
- [37] Spontaneous Transformation from EGFR and ALK Wild-Type Lung Adenocarcinoma to Neuroendocrine CarcinomaJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : E126 - E128Kage, HidenoriKohsaka, ShinjiShinozaki-Ushiku, AyaUshiku, TetsuoTakai, DaiyaNakajima, JunMiyagawa, KiyoshiAburatani, HiroyukiMano, HiroyukiNagase, Takahide
- [38] Clinical impact of amphiregulin expression in EGFR wild-type non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Chang, M.Lee, J.Jung, C.Park, Y.Ahn, J.Park, K.Ahn, M.
- [39] Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung AdenocarcinomaDISEASE MARKERS, 2021, 2021Luo, Jia-WeiGuo, Yan-HuaWu, Feng-YingLi, Xue-FeiSun, Xue-ChengWang, Jia-LuZhou, Cai-Cun
- [40] KRAS MUTATION IN EGFR WILD TYPE INDONESIAN LUNG CANCER PATIENTRESPIROLOGY, 2017, 22 : 73 - 73Masykura, NajmiatulKharunisa, Bela HaifaZaini, JamalAndarini, Sita LaksmiHudoyo, AchmadSyahruddin, ElisnaHidajat, HeriawatyWidjajahakim, GraceUtomo, Ahmad